Literature DB >> 16634374

Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity.

D Shepshelovich1, Y Shoenfeld.   

Abstract

Autoimmune connective tissue diseases are chronic, potentially life threatening complex multisystem disorders. Their etiology is unknown but genetic, hormonal and environmental factors are important. The clinical disease is preceded by a long period of time (sometimes many years) when the patients can be identified by characteristic antibodies in their serum. When such a patient is identified he is usually followed and treated if clinical disease manifests itself. However, other factors besides the existence of autoantibodies have a predictive value for those disorders; some of them hereditary or genetic, and can be used only to predict likelihood of future disease, and others, connected to lifestyle and environment, could be modified in order to try and prevent it. Several non-randomized small scale studies have suggested that autoimmune disease could be prevented if treated aggressively prior to manifestations of symptoms. However, if such is the case, criteria would have to be formalized for selection of patients for this preventive treatment. Only patients whose probability to develop clinical disease is higher then a certain threshold should be treated while asymptomatic. The aim of this article is to review the major risk factors for autoimmune disease, both hereditary and environmental, and so to help define those future criteria. Individuals who are at risk to develop an autoimmune disease should be advised to refrain from activities and lifestyle which endangers their health and quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634374     DOI: 10.1191/0961203306lu2274rr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma.

Authors:  W Miesbach; I Scharrer; R A Asherson
Journal:  Clin Rheumatol       Date:  2006-05-24       Impact factor: 2.980

2.  Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives.

Authors:  Susan L Neuhausen; Linda Steele; Sarah Ryan; Maryam Mousavi; Marie Pinto; Kathryn E Osann; Pamela Flodman; John J Zone
Journal:  J Autoimmun       Date:  2008-08-08       Impact factor: 7.094

3.  The spectrum between antiphospholipid syndrome and systemic lupus erythematosus.

Authors:  Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2014-03       Impact factor: 2.980

4.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 5.  Immune Privilege Collapse and Alopecia Development: Is Stress a Factor.

Authors:  Soraya Azzawi; Lauren R Penzi; Maryanne M Senna
Journal:  Skin Appendage Disord       Date:  2017-12-20

Review 6.  Clinical implications of shared genetics and pathogenesis in autoimmune diseases.

Authors:  Alexandra Zhernakova; Sebo Withoff; Cisca Wijmenga
Journal:  Nat Rev Endocrinol       Date:  2013-08-20       Impact factor: 43.330

Review 7.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis.

Authors:  Jorge Cárdenas-Roldán; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

Review 8.  Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.

Authors:  Chiara Spinello; Giovanni Laviola; Simone Macrì
Journal:  Front Neurosci       Date:  2016-06-30       Impact factor: 4.677

Review 9.  Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Cristina Belizna; Albert Selva-O'Callaghan; Josep Pardos-Gea; Angela Quintana; Arsene Mekinian; Ariadna Anunciacion-Llunell; Francesc Miró-Mur
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

Review 10.  Psychological Stress, Intestinal Barrier Dysfunctions, and Autoimmune Disorders: An Overview.

Authors:  Hanna Ilchmann-Diounou; Sandrine Menard
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.